EcoDrugPlus

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSEEUG00000007105
Gene Symbol: PTPRB
1 External references
268 Possible Orthologues:

Purine Nucleoside Phosphorylase

Ensembl ID : ENSEEUG00000002411
Gene Symbol: PNP
4 External references
123 Possible Orthologues:

Purinergic Receptor P2x 7

Ensembl ID : ENSEEUG00000015942
Gene Symbol: P2RX7
1 External references
195 Possible Orthologues:

Purinergic Receptor P2y1

Ensembl ID : ENSEEUG00000013748
Gene Symbol: P2RY1
1 External references
191 Possible Orthologues:

Purinergic Receptor P2y12

Ensembl ID : ENSEEUG00000011349
Gene Symbol: P2RY12
1 External references
182 Possible Orthologues:

Pyrimidinergic Receptor P2y6

Ensembl ID : ENSEEUG00000007903
Gene Symbol: P2RY6
4 External references
183 Possible Orthologues:

Receptor Activity Modifying Protein 1

Ensembl ID : ENSEEUG00000013280
Gene Symbol: RAMP1
1 External references
252 Possible Orthologues:

Receptor Interacting Serine/threonine Kinase 1

Ensembl ID : ENSEEUG00000003534
Gene Symbol: RIPK1
1 External references
198 Possible Orthologues:

Regulatory Associated Protein Of Mtor Complex 1

Ensembl ID : ENSEEUG00000002970
Gene Symbol: RPTOR
1 External references
209 Possible Orthologues:

Renin

Ensembl ID : ENSEEUG00000001053
Gene Symbol: REN
3 External references
220 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSEEUG00000006140
Gene Symbol: RARB
1 External references
451 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSEEUG00000012904
Gene Symbol: RARG
1 External references
453 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).